Close

Hepion Pharmaceuticals (HEPA) Reports DSMB Recommends Continuation with Final Dose Cohort in Phase 2a 'AMBITION' Clinical Trial for Treatment of Advanced NASH Dec 29, 2020 07:34AM
Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a 'AMBITION' Clinical Trial for Treatment of Advanced NASH Dec 29, 2020 07:30AM